INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Vanda Pharmaceuticals Inc.
February 11 2019 - 7:00PM
Business Wire
The law firm of Kirby McInerney LLP is investigating potential
claims against Vanda Pharmaceuticals, Inc. (“Vanda” or the
“Company”) (NASDAQ: VNDA). This investigation concerns whether
Vanda has violated federal securities laws and/or engaged in other
unlawful business practices.
On February 11, 2019, Aurelius Value published an article
reporting that a qui tam lawsuit filed by a whistleblower was
recently unsealed, containing allegations of “illegal off-label
promotion of both of Vanda’s drugs, Vanda’s participation in a
fraud involving doctors writing hundreds of ‘fake prescriptions’
and pocketing cash using Vanda-issued copay cards, falsified
documents in internal systems, and resignations of senior
executives who refused to participate in illegal activity.”
On this news, shares of Vanda fell $0.95 per share or
approximately 5%, to close at $18.00 on February 11, 2019.
If you acquired Vanda securities, have information, or would
like to learn more about these claims, please contact Thomas W.
Elrod of Kirby McInerney LLP at 212-371-6600, by email at
investigations@kmllp.com, or by filling out this contact form, to
discuss your rights or interests with respect to these matters
without any cost to you.
Kirby McInerney LLP is a New York-based plaintiffs’ law firm
concentrating in securities, antitrust, and whistleblower
litigation. The firm’s efforts on behalf of shareholders in
securities litigation have resulted in recoveries totaling billions
of dollars. Additional information about the firm can be found at
Kirby McInerney LLP’s website: www.kmllp.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190211005803/en/
Kirby McInerney LLPThomas W. Elrod, Esq., (212)
371-6600investigations@kmllp.comwww.kmllp.com
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Sep 2023 to Sep 2024